B
BioXcel Therapeutics, Inc. Common StockBTAI
BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a biopharmaceutical company built on artificial intelligence ('AI') to develop transformative medicines in neuroscience. Its wholly owned subsidiary, OnkosXcel Therapeutics, is focused on the development of medicines in.
US StocksHealthcareSmall CapArtificial IntelligenceBiotechnologyGrowth Stocks
BTAI 가격 추세
BioXcel Therapeutics, Inc. Common Stock · TradingView 전체 차트
NASDAQ:BTAI